Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
<h4>Background</h4>An increased risk of myocarditis or pericarditis after priming with mRNA Coronavirus Disease 2019 (COVID-19) vaccines has been shown but information on the risk post-booster is limited. With the now high prevalence of prior Severe Acute Respiratory Syndrome Coronavirus...
Saved in:
| Main Authors: | Julia Stowe, Elizabeth Miller, Nick Andrews, Heather J Whitaker |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-06-01
|
| Series: | PLoS Medicine |
| Online Access: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004245&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Myocarditis and pericarditis after vaccination for COVID‐19
by: Blake Hudson, et al.
Published: (2021-08-01) -
Response to case report on myocarditis and pericarditis after COVID‐19 vaccination
by: Rujittika Mungmunpuntipantip, et al.
Published: (2021-10-01) -
Systematic review of spontaneous reports of myocarditis and pericarditis in transplant recipients and immunocompromised patients following COVID-19 mRNA vaccination
by: Saad Shakir, et al.
Published: (2022-07-01) -
Genome-wide association study of myocarditis and pericarditis following COVID-19 vaccination
by: Marco Cavalli, et al.
Published: (2025-05-01) -
Surveillance and follow up outcomes of myocarditis after mRNA COVID-19 vaccination in Australia
by: Lucy Deng, et al.
Published: (2025-07-01)